Submit Deal

ARKIN BIO VENTURES

HQ - Herzliya, Israel

Summary

Arkin Bio is a life sciences investment firm focused on clinical-stage biotech companies.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 395 M

Avg. Deal Size£ 79 M

Market Context

Senior Management

Alon Lazarus
Investment manager

Sort

bluejay therapeutics

HQ - United States

Biotechnology

16 Aug 2022

Investment Date

£ 33 M

Deal Value

photys therapeutics

HQ - United States

Health Care Services

8 Sep 2022

Investment Date

£ 65 M

Deal Value

human immunology biosciences

HQ - United States

Biotechnology

4 Jan 2024

Investment Date

£ 75 M

Deal Value

bluejay therapeutics

HQ - United States

Biotechnology

9 May 2024

Investment Date

£ 145 M

Deal Value

newleos therapeutics inc

HQ - United States

Biotechnology

13 Feb 2025

Investment Date

£ 75 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy